Site growth

Building a strong relationship with your CRA

By TrialNotice · Updated
Hands annotating a printed clinical trial protocol with colored tabs and a highlighter
Short answerYour clinical research associate (CRA) is the sponsor's eyes on your site, so the relationship shapes your reputation and future selection. Make monitoring visits efficient with organized source documents and resolved queries, communicate problems early, and plan for turnover, since the CRO industry sees high staff churn. A CRA who trusts your site recommends it for the next study.

Why does the CRA relationship matter?

The CRA reports on your data quality, enrollment, and compliance to the sponsor. Those reports, along with metrics like enrollment rates and startup times, feed the performance records sponsors use to pick sites (IQVIA). A CRA who sees a well run site becomes an advocate inside the sponsor or CRO.

What makes monitoring visits go well?

  1. Organized source documents and regulatory binders, ready before the visit.
  2. Queries resolved before the CRA arrives, not during.
  3. A quiet workspace and access to the people they need.
  4. A short agenda agreed in advance.
  5. Same day follow up on any findings.

How do you handle CRA turnover?

Expect it. ACRP reported more than 25% turnover among clinical research professionals at CROs, citing BDO's industry survey (ACRP). Keep a site orientation packet for new CRAs: contacts, workflows, open issues, and study history. Some institutions bill a fee for monitor changes, such as $500 per change (LSU Health), because onboarding a new CRA takes real staff time.

How do you communicate problems?

Early and specifically. A CRA who hears about a slow enrollment month from you, with a plan, can defend your site. A CRA who discovers it in the data cannot.

What helps most when enrollment is the problem?

A credible plan. Telling your CRA "we are adding outreach to the 30 specialists who manage this condition within 20 miles, with letters going out this week" turns a problem into a story of a site that acts. See the enrollment recovery plan.

Get your study in front of the right local physicians

TrialNotice builds a physician referral pipeline around one active study. We identify relevant local physicians within driving distance of your site, send study aligned direct mail, follow up by email and LinkedIn, track engagement with recipient level QR codes, and route warm responses into your site team's workflow.

Talk to TrialNotice

Sources

  1. ACRP, "State of the Clinical Research Workforce" report (2020)
  2. Augusta University, "Clinical Research Coordinator: Salary, Job Description and Requirements" (citing Payscale)
  3. LSU Health New Orleans Clinical Trials Office, Budget Development training
  4. IQVIA, "Today's Investigator Databank and DQS: Welcoming the Next Generation of Consortium Members" (2025)

Keep reading

Two clinical research site staff members reviewing a growth plan together in a bright office
Site growth

How to grow a clinical research site: a practical playbook

Research sites grow by building a record sponsors can verify: enrollment, startup speed, and screen failure. Here is what the data says about site growth, why sponsors reuse sites, and a six step playbook.

 Research site director presenting enrollment results to sponsor representatives across a conference table
Site growth

How research sites get more studies from sponsors and CROs

Sponsors award more studies to sites that enroll reliably, start fast, and forecast honestly. Here is how sponsors choose, why new sites face a slower path, and what a site can do to win repeat work.

 Sponsor clinical operations team reviewing site maps and performance charts on a large screen
Site growth

How sponsors and CROs select clinical trial sites

Sponsors shortlist sites with historical data and epidemiology, send feasibility questionnaires, then choose on patient access, past enrollment, and startup speed. Here is the process, how it evolved, and what it means for sites.